欢迎访问《标记免疫分析与临床》官方网站!
分化型甲状腺癌131I治疗后第二原发恶性肿瘤发生情况的研究进展
石 磊,王 璐,吴兴勇,胡德胜
The Research Progress of the Second Primary Malignant after the Treatment of Differentiated Thyroid Cancer with 131I
SHI Lei,WANG Lu,WU Xing-yong,HU De-sheng
标记免疫分析与临床 . 2019, (7): 1236 -1239 .  DOI: 10.11748/bjmy.issn.1006-1703.2019.07.037